Skip to content

H5N1 reaches Antarctica – concern for wildlife and global consequences

The highly pathogenic avian influenza H5N1 has reached Antarctica for the first time, causing significant wildlife losses. The virus, which originally circulated in Asia and has spread globally in recent years, was first detected on the Antarctic mainland in February 2024. Researchers believe that migratory birds from South America introduced the virus. Affected species, including various seabirds and seals, typically show severe neurological and respiratory symptoms. Mortality rates are high as the animals have no immunity to the pathogen. In recent months, an increasing number of dead or severely ill animals have been found at several Antarctic research stations and along various coastlines. Colonies of brown skuas, giant petrels, and albatrosses are particularly affected, but the virus has also been detected in seal species such as crabeater seals and leopard seals. The spread is rapid, as many bird species breed in large colonies and the virus...

KAIST Develops Virtual Staining Technology for 3D Histology

An international research team led by KAIST has developed a groundbreaking technology that goes beyond traditional methods of examining thinly sliced and stained cancer tissue. This innovation utilizes advanced optical techniques combined with an artificial intelligence-based deep learning algorithm to create realistic, virtually stained 3D images of cancer tissue without the need for serial sectioning or staining. This breakthrough is expected to pave the way for the next generation of non-invasive pathological diagnostics. For over 200 years, conventional pathology has relied on examining cancer tissue under a microscope. However, this method only reveals specific cross-sections of the three-dimensional cancer tissue, limiting the understanding of the three-dimensional connections and spatial arrangements between cells. To address this issue, the research team employed holotomography (HT), an advanced optical technology, to measure the three-dimensional refractive index of tissue. They then integrated an AI-based deep learning algorithm to successfully...

Typisch schwarze Kolonien von Diphtheriebakterien Corynebacterium diphtheriae kultiviert am Institut für Medizinische Mikrobiologie auf einem speziellen Nährmedium in einer Petrischale | Quelle Farah Fiechter und Frank Imkamp | Copyright Universität Zürich

Diphtheria Outbreak 2022: Transmission Routes Along Migration Routes Deciphered

In 2022, a diphtheria outbreak in Western Europe led to the sharpest increase in reported infections in 70 years. A study by a European research consortium, published in the New England Journal of Medicine, has now traced the transmission routes for the first time. Clinical and genomic data point to infection sources along established migration routes to Europe, particularly the Balkan route. Despite rapid containment, bacterial strains from this outbreak continue to cause isolated new infections, requiring ongoing vigilance. Diphtheria, a notifiable infectious disease caused by the bacterium Corynebacterium diphtheriae, was registered unusually frequently in several European countries in 2022. The cases primarily affected refugees who had recently arrived in Europe, while infections in the local population were not documented. The study analyzed 363 bacterial isolates from ten countries – Germany (118), Austria (66), United Kingdom (59), Switzerland (52), France (30), Belgium (21), Norway (8), Netherlands (5), Italy (3), and Spain (1) – and provided… 

AI-powered model aims to improve stroke treatment

Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the University Hospital Bonn are developing an AI-based computer model to support doctors in stroke treatment. The goal is a digital assistance system that predicts health status after mechanical thrombectomy and detects complications to optimize therapy decisions. A feasibility study is examining whether this is possible with data from the "German Stroke Registry" and brain imaging. The project, funded with 250,000 euros by the Helmholtz Association, uses the innovative AI technology of "swarm learning" and involves the CISPA Helmholtz Center for Information Security. An ischemic stroke, often caused by blood clots, leads to neurological deficits such as paralysis or speech disorders. Without rapid treatment, millions of brain cells die. Treatment options such as drug-induced clot lysis or minimally invasive thrombectomy require quick, individual decisions. The planned AI model is intended to provide predictions about treatment success and risks, with the "explainability" of the AI ensuring that doctors understand the basis of the… 

Origin of Life: Metabolism of the First Cells Reconstructed

Ein Forschungsteam unter der Leitung von Mikrobiologin Prof. Dr. Dina Grohmann von der Universität Regensburg und Geologe Prof. Dr. William Orsi von der LMU München hat im Labor Bedingungen der jungen Erde vor etwa vier Milliarden Jahren nachgestellt. Der Fokus lag auf hydrothermalen Quellen am Meeresboden, sogenannten „Schwarzen Rauchern“. Die kürzlich in Nature Ecology & Evolution veröffentlichten Ergebnisse liefern neue Erkenntnisse über die Ursprünge des Lebens und einen der ältesten biochemischen Energiegewinnungswege. Im Experiment wurden Miniaturausgaben von „Schwarzen Rauchern“, sogenannte „Chemical Gardens“, erzeugt, die Reaktionen am Meeresgrund simulieren. Dabei entstanden durch die Reaktion von Eisen und Schwefel Eisensulfid-Minerale wie Mackinawit und Greigit sowie Wasserstoffgas – eine potenzielle Energiequelle für Mikroorganismen. Die Forscher untersuchten, ob dieser Wasserstoff methanogene Archaeen, die Methan durch den Acetyl-CoA-Stoffwechselweg produzieren, zum Wachstum antreiben kann. Unter sauerstofffreien Bedingungen, die durch die langjährige Expertise des Deutschen Archaeenzentrums ermöglicht… 

Fraunhofer IAF erweitert Quantencomputing-Infrastruktur mit innovativem Quantenbeschleuniger

Das Fraunhofer-Institut für Angewandte Festkörperphysik IAF in Freiburg hat im Juni 2025 seine einzigartige Quantencomputing-Infrastruktur um einen bahnbrechenden Quantenbeschleuniger des deutsch-australischen Herstellers Quantum Brilliance erweitert. Das Quantum Development Kit der zweiten Generation (QB-QDK2.0) ist Europas erster kompakter Quantenbeschleuniger, der auf Stickstoff-Vakanz-Zentren (NV-Zentren) in Diamant basiert. Mit seinem platzsparenden Design und der Fähigkeit, ohne aufwendige Kryotechnik auszukommen, setzt das System neue Maßstäbe für hybrides quanten-klassiches Computing und steht Partnern aus Wissenschaft und Industrie zur Verfügung, um reale Quantenanwendungen zu erforschen. Kompakte Technologie für die Zukunft Das QB-QDK2.0 wurde nach einer öffentlichen Ausschreibung in die Hochleistungsrechner-Infrastruktur des Fraunhofer IAF integriert und ist seit Juni 2025 betriebsbereit. Das System passt in ein standardmäßiges 19-Zoll-Serverrack, wodurch es sich problemlos in bestehende IT-Umgebungen einfügt. Im Gegensatz zu herkömmlichen Quantencomputern, die komplexe Kühlsysteme benötigen, arbeitet der Quantenbeschleuniger bei Raumtemperatur und ist dadurch besonders energieeffizient. Diese Eigenschaften… 

FAQ: What costs does a member of the Bundestag incur for taxpayers?

The costs incurred by a member of the Bundestag for taxpayers are composed of various components, including allowances, office expenses, travel expenses, and other benefits. Below, we answer the most important questions on this topic, based on current information (as of 2025). 1. What is the allowance of a member of the Bundestag and how much is it? The allowance is the basic remuneration of a member of the Bundestag. It is intended to make members financially independent and enable their work. In 2025, the monthly allowance will be approximately €10,591.70 (as of: July 2024, automatically adjusted for the cost of living). The allowance is taxable, although members can reduce their tax burden by claiming flat-rate deductions. 2. What additional allowances do members receive? In addition to the allowance, there are other allowances that are tax-free or partially tax-free: 3. What travel expenses are reimbursed? Members regularly travel between Berlin and their constituency. The costs for this are covered as follows:… 

FAQ: How can I study medicine without a Numerus Clausus?

  • News

Studying medicine in Germany is often difficult to access due to the Numerus Clausus (NC). However, there are ways to study medicine even without a perfect Abitur grade. This FAQ article answers the most common questions on this topic. 1. What is the Numerus Clausus (NC) in medical studies? The Numerus Clausus is an admission restriction introduced due to limited study places and high demand. The NC varies annually and for medicine is often an Abitur average of 1.0 to 1.3, depending on the university. 2. Can I study medicine in Germany without an NC? In Germany, there is no possibility to study medicine completely without an NC at public universities, as all state medical degree programs are subject to admission restrictions. However, there are alternatives to bypass or compensate for the NC hurdle. 3. What alternatives are there to study medicine despite the NC? There are several ways to study medicine, even if… 

Interest rate cuts in the USA: Why Ripple XRP could rise to $30

Washington, D.C., June 4, 2025 – The expected interest rate cuts by the U.S. Federal Reserve could have a significant impact on financial markets in the coming months, particularly on the cryptocurrency sector. One cryptocurrency that could particularly benefit from this development is Ripple (XRP). The token, designed for cross-border payments, faces a potential price surge that could catapult it from its current price of around $2.25 to as high as $30. This report analyzes the economic mechanisms that could fuel this increase and highlights specific examples that support the dynamics. Interest Rate Cuts and Their Impact on Financial Markets The Federal Reserve has pursued a restrictive monetary policy in recent years to combat inflation, which peaked in 2022. With interest rates at times above 5.5%, risky assets such as stocks and cryptocurrencies have come under pressure as investors sought safer investments… 

Interest Rate Cuts as a Growth Engine for the US Pharmaceutical Industry

  • News

The interest rate cuts demanded by Donald Trump could give the US pharmaceutical industry a significant boost. Companies like Pfizer, Moderna, and Amgen could benefit from lower financing costs and increased investment. However, inflation, price pressure, and customs policy pose risks that require a differentiated analysis. The US pharmaceutical industry, a global leader in innovation, faces complex challenges: high research and development costs, expiring patents, and political price pressure shape the industry. In this environment, President Donald Trump has repeatedly called for interest rate cuts by the Federal Reserve (Fed) to stimulate the economy. In September 2024, the Fed lowered the key interest rate by 50 basis points to 4.75–5.00%, and Trump is pushing for further easing. This report analyzes how interest rate cuts could affect the US pharmaceutical industry, particularly companies like Pfizer, Moderna, Amgen, and Gilead Sciences, and highlights opportunities and risks based on concrete facts. The Context: Trump's Interest Rate Policy and the Pharmaceutical Industry The US pharmaceutical industry generated revenues of…  in 2024